Jennifer Morganroth

Dr. Jennifer Morganroth, a Neuromuscular and EMG fellow at Columbia, discusses the dramatic increase in thymectomy procedures for myasthenia gravis since the groundbreaking MGTX trial in 2016. She highlights significant disparities in access to these surgeries, especially among African-American patients and women. The conversation also delves into the impact of hospital characteristics and patient communication on treatment availability. Moreover, they explore the shift towards minimally invasive surgical techniques and the implications of new non-surgical treatments for future practices.